References
- Weidraann P, Uehlinger D E, Gerber A. Antihypertensive treatment and serum lipoproteins. J Hypertension 1985; 3: 297–306
- Lehtonen A. Effect of beta-blockers on plasma lipids during antihypertensive therapy. J Cardiovasc Pharmacol 1985; 7: S110–S114
- Ames R P. The effects of antihypertensive drugs on serum lipids and lipoproteins. Drugs 1986; 32: 335–357
- Multiple Risk Factor Intervention Trial Research Group. Hypertension management in the Multiple Risk Factor Interventention Trial (MRFIT). Six year intervention results for men in special intervention and usual care groups. Arch Intern Med 1985; 145: 1191–1199
- Henry P D, Bentley K L. Suppression of atherogenesis in cholerolfed rabbit treated with nifedipine. J Clin Invest 1981; 68: 1366–1369
- Henry P D. Atherosclerosis, calcium and calcium antagonists. Circulation 1985; 72: 456–45
- Fuller I H, Shipley M J, Rose G, Jar rets J R, Keen H. Coronary heart disease risk and impaired glucose tolerance. Lancet 1980; 1: 1373–1376
- Trost B N, Weidmann P. Effects of calcium antagonists on glucose homeostasis and serum lipids in non-diabetic and diabetic subjects: A review. J Hypertension 1987; 5(Suppl 4)81–104
- Franz I W, Wievel D. Antihypertensive Wirkung von Nitrendipin, Nifedipin und Acebutolol und deren Kombination auf den Ruhe- und Belastungsblutdruck bei Hochdruckkranken. Z Kardiol 1985; 74: 111–116
- Fagan T C, Nelson E B, Lasseter K C, Crook J, Morledge J, Konrad K A. Once- and twice-daily nitrendipine in patients with hypertension and non-insulin dependent diabetes. Pharmacotherapy 1986; 6: 128–136
- Vessby B, Abelin J, Finnson M, Hellsing K, Lithell H. Effects of nifedipine treatment on carbohydrate and lipoprotein metabolism. Curr Ther Res 1983; 33: 1075–1081
- Lehtonen A, Gordin A. Metabolic parameters after changing, from hydrochlorothiazide to verapamil treatment in hypertension. Eur J Clin Pharmacol 1984; 27: 153–157
- Lehtonen A, Gordin A, Salo H. Comparison of sustained release verapamil and hydrochlorothiazide in hypertension - effect on blood pressure and metabolic variables. Int J Clin Pharmacol Ther Toxicol 1987; 25: 301–305
- Francischetti E A, Oigman W, Fagundes V GA, Sanjuliani A F, Cunha M C. Long-term therapy with nitrendipine: evaluation of its antihypertensives and metabolic effects. J Cardiovasc Pharmacol 1987; 9(Suppl 4)S107–S112
- Walldius G. Effect of verapamil on serum lipoproteins in patients with angina pectoris. Acta Med Scand 1984; 681(Suppl)43–48
- Pool P E, Seagren S C, Salel A F, Skalland M L. Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind, placebo-controlled evaluation for systemic hypertension. Am J Cardiol 1985; 56: 86H–91H
- Pollare T, Lithell A, Mörlin C, Präntare H, Hvarfner A, Ljunghall S. Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups. J Hypertension 1989; 7: 551–559